Concord Biotech Limited — Important, 08-10-2025: Updates
08-10-2025 | 11:07 am
08-10-2025 | 11:07 am
Concord Biotech successfully completed a NAFDAC inspection at its Valthera Oral Solid Dosage Unit-2 facility. This reinforces the company's commitment to high quality, safety, and global regulatory compliance, supporting continued market access and operational stability.
No comments yet. Be the first to comment!
